21 CFR 211.1 - Scope of 21 CFR Part 211

What it says

21 CFR 211.1 defines the scope of Part 211, establishing that the regulations contain the minimum current good manufacturing practice requirements for the preparation of drug products for administration to humans or animals, applicable to the manufacture, processing, packing or holding of any drug.

Paraphrased for plain-language clarity. Always verify against the current published regulation text.

What it means in practice

• Part 211 is explicitly framed as minimum requirements, meaning full compliance with the letter of each provision is a floor, not necessarily a ceiling, and a manufacturer can and often should exceed these minimums based on product-specific risk.
• The scope explicitly covers processing, packing and holding activities, not only active manufacturing, meaning contract packagers, warehousing operations and similar activities fall within Part 211's reach even without direct manufacturing involvement.
• Understanding this provision correctly frames every other Part 211 requirement covered elsewhere in this library as sitting within a deliberately minimum-standard framework, not an exhaustive description of everything good manufacturing practice could require.

What FDA inspectors look for

• Whether all activities within Part 211's actual scope, including packing and holding operations that might be organisationally distinct from core manufacturing, are brought under the same cGMP compliance framework.
• Whether a site's compliance posture reflects genuine understanding that these are minimum requirements, rather than treating literal compliance with each specific provision as automatically sufficient regardless of actual product risk.

Related regulations